• Skip to main content
  • Skip to primary sidebar

Tracking Health and Wellness Applications of Brain Science

Spanish
sb-logo-with-brain
  • Resources
    • Monthly eNewsletter
    • Solving the Brain Fitness Puzzle
    • The SharpBrains Guide to Brain Fitness
    • How to evaluate brain training claims
    • Resources at a Glance
  • Brain Teasers
    • Top 25 Brain Teasers & Games for Teens and Adults
    • Brain Teasers for each Cognitive Ability
    • More Mind Teasers & Games for Adults of any Age
  • Virtual Summits
    • 2019 SharpBrains Virtual Summit
    • Speaker Roster
    • Brainnovations Pitch Contest
    • 2017 SharpBrains Virtual Summit
    • 2016 SharpBrains Virtual Summit
    • 2015 SharpBrains Virtual Summit
    • 2014 SharpBrains Virtual Summit
  • Report: Pervasive Neurotechnology
  • Report: Digital Brain Health
  • About
    • Mission & Team
    • Endorsements
    • Public Speaking
    • In the News
    • Contact Us

medications

Study: Self-guided sleep app Sleepio, combined with standard care for depression and anxiety, delivers better outcomes than standard care alone

September 27, 2021 by SharpBrains

Study backs ben­e­fit of insom­nia DTx Sleepio on men­tal health (pharmapho­rum):

The study – pub­lished in the jour­nal Behav­iour Research and Ther­a­py – test­ed the Sleepio app devel­oped by dig­i­tal health spe­cial­ist Big Health as an add-on to stan­dard NHS care for anx­i­ety and depres­sion under the improv­ing access to psy­cho­log­i­cal ther­a­pies (IAPT) policy.

Patients who signed up to use Sleepio – a six-week dig­i­tal cog­ni­tive behav­iour­al ther­a­py (CBT) course – achieved sig­nif­i­cant­ly bet­ter improve­ment in symp­toms com­pared to con­trols, with an IAPT recov­ery rate of near­ly 65% ver­sus 58% in the con­trol group. [Read more…] about Study: Self-guid­ed sleep app Sleepio, com­bined with stan­dard care for depres­sion and anx­i­ety, deliv­ers bet­ter out­comes than stan­dard care alone

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Brain/ Mental Health, Technology & Innovation Tagged With: anxiety, app, Behaviour Research and Therapy, Big Health, cognitive behavioural therapy, depression, digital CBT, digital cognitive behavioural therapy, digital health, insomnia, insomnia DTx, medications, National Institute for Health and Care Excellence, NHS, NICE, psychological therapies, Sleepio, therapy

Anticholinergic drugs found to significantly increase risk of cognitive decline, especially among those with Alzheimer’s Disease biomarkers or genetic predisposition

September 11, 2020 by SharpBrains

Com­mon Class of Drugs Linked to Increased Risk of Alzheimer’s Dis­ease (UC San Diego release):

A team of sci­en­tists, led by researchers at Uni­ver­si­ty of Cal­i­for­nia San Diego School of Med­i­cine, report that a class of drugs used for a broad array of con­di­tions, from aller­gies and colds to hyper­ten­sion and uri­nary incon­ti­nence, may be asso­ci­at­ed with an increased risk of cog­ni­tive decline, par­tic­u­lar­ly in old­er adults at greater risk for Alzheimer’s dis­ease (AD) … cog­ni­tive­ly nor­mal study par­tic­i­pants who were tak­ing at least one anti­cholin­er­gic drug at base­line were 47 per­cent more like­ly to devel­op mild cog­ni­tive impair­ment (MCI), often a pre­cur­sor to demen­tia such as AD, while being tracked over a peri­od of up to a decade com­pared to par­tic­i­pants who did not take such drugs. [Read more…] about Anti­cholin­er­gic drugs found to sig­nif­i­cant­ly increase risk of cog­ni­tive decline, espe­cial­ly among those with Alzheimer’s Dis­ease bio­mark­ers or genet­ic predisposition

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Brain/ Mental Health Tagged With: Alzheimer’s Disease, anticholinergic, anticholinergic medications, biomarkers, cognition, cognitive, cognitive decline, cognitively, dementia, lower cognitive abilities, lower cognitive ability, MCI, medications, mild-cognitive-impairment, older-adults, University of California San Diego

Reminder: A brain-friendly lifestyle is the best approach to delay cognitive decline and dementia

November 18, 2019 by SharpBrains

While the hip­pocam­pus tends to shrink with age, which con­tributes to cog­ni­tive decline, a recent study shows that this is not always the case (see all those blue lines), sug­gest­ing it can be pos­si­ble to main­tain hip­pocam­pus vol­ume and cog­ni­tive func­tion into our lat­er years.

_______

What Sci­ence Tells Us About Pre­vent­ing Demen­tia (The Wall Street Journal):

“When it comes to bat­tling demen­tia, the unfor­tu­nate news is this: Med­ica­tions have proven inef­fec­tive at cur­ing or stop­ping the dis­ease and its most com­mon form, Alzheimer’s dis­ease. But that isn’t the end of the sto­ry. Accord­ing to a recent wave of sci­en­tif­ic stud­ies, we have more con­trol over our cog­ni­tive health than is com­mon­ly known. We just have to take cer­tain steps—ideally, ear­ly and often—to live a health­i­er lifestyle.

In fact, accord­ing to a recent report com­mis­sioned by the Lancet, a med­ical jour­nal, around 35% of demen­tia cas­es might be pre­vent­ed if [Read more…] about Reminder: A brain-friend­ly lifestyle is the best approach to delay cog­ni­tive decline and dementia

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Brain/ Mental Health, Education & Lifelong Learning Tagged With: aging, Alzheimer’s Disease, brain-friendly, cognitive-health, dementia, dementia prevention, lifestyle, medications

Think twice before taking Aderall for cognitive enhancement: It may actually impair working memory and other cognitive abilities

July 23, 2018 by SharpBrains

___

ADHD drugs do not improve cog­ni­tion in healthy col­lege stu­dents (Sci­enceDai­ly):

“Con­trary to pop­u­lar belief across col­lege cam­pus­es, atten­tion deficit hyper­ac­tiv­i­ty dis­or­der (ADHD) med­ica­tions may fail to improve cog­ni­tion in healthy stu­dents and actu­al­ly can impair func­tion­ing, accord­ing to a study by researchers at the Uni­ver­si­ty of Rhode Island and Brown Uni­ver­si­ty. [Read more…] about Think twice before tak­ing Ader­all for cog­ni­tive enhance­ment: It may actu­al­ly impair work­ing mem­o­ry and oth­er cog­ni­tive abilities

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Attention & ADD/ADHD, Brain/ Mental Health, Peak Performance Tagged With: amphetamine, attention deficit hyperactivity disorder, cognitive, cognitive-abilities, emotional, improve-cognition, medications, neurocognition, prescription, prescription stimulant medications, psychostimulants, stimulant, Working-memory

When Healthcare ignores Mental Health: 200 common prescription medications increase depression risk

June 15, 2018 by SharpBrains

___

Many Amer­i­cans tak­ing com­mon meds that may cause depres­sion, study finds (CBS News):

“More than one-third of U.S. adults are tak­ing pre­scrip­tion med­ica­tions that may lead to depres­sion, new research finds. The study, pub­lished in the Jour­nal of the Amer­i­can Med­ical Asso­ci­a­tion, warns that depres­sion is a poten­tial side effect of more than 200 com­mon­ly pre­scribed med­ica­tions, [Read more…] about When Health­care ignores Men­tal Health: 200 com­mon pre­scrip­tion med­ica­tions increase depres­sion risk

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Brain/ Mental Health, Education & Lifelong Learning Tagged With: adults, beta-blockers, depression, healthcare, medications, Mental-Health, prescription, prescription medications

Study: For good and bad, TV ads promote higher prescribing volume of psychiatric medications

November 11, 2016 by SharpBrains

couple_watching_televisionHow Are Direct-to-Con­sumer-Adver­tise­ments Chang­ing Psy­chi­atric Drug Use? (The Dana Foundation):

“Flip on your tele­vi­sion to a com­mer­cial sta­tion and you are like­ly to see ads for cars, snacks, and home appliances—and pre­scrip­tion med­ica­tions. Some ads specif­i­cal­ly tar­get psy­chi­atric ill­ness­es [Read more…] about Study: For good and bad, TV ads pro­mote high­er pre­scrib­ing vol­ume of psy­chi­atric medications

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Brain/ Mental Health Tagged With: anti-depressants, bipolar depression, FDA, medications, Mental-Health, prescription, prescription medications, psychiatric medications, psychiatry, public-health

Next Page »

Primary Sidebar

Top Articles on Brain Health and Neuroplasticity

  1. Can you grow your hippocampus? Yes. Here’s how, and why it matters
  2. How learning changes your brain
  3. To harness neuroplasticity, start with enthusiasm
  4. Three ways to protect your mental health during –and after– COVID-19
  5. Why you turn down the radio when you're lost
  6. Solving the Brain Fitness Puzzle Is the Key to Self-Empowered Aging
  7. Ten neu­rotech­nolo­gies about to trans­form brain enhance­ment & health
  8. Five reasons the future of brain enhancement is digital, pervasive and (hopefully) bright
  9. What Educators and Parents Should Know About Neuroplasticity and Dance
  10. The Ten Habits of Highly Effective Brains
  11. Six tips to build resilience and prevent brain-damaging stress
  12. Can brain training work? Yes, if it meets these 5 conditions
  13. What are cognitive abilities and how to boost them?
  14. Eight Tips To Remember What You Read
  15. Twenty Must-Know Facts to Harness Neuroplasticity and Improve Brain Health

Top 10 Brain Teasers and Illusions

  1. You think you know the colors? Try the Stroop Test
  2. Check out this brief attention experiment
  3. Test your stress level
  4. Guess: Are there more brain connections or leaves in the Amazon?
  5. Quick brain teasers to flex two key men­tal mus­cles
  6. Count the Fs in this sentence
  7. Can you iden­tify Apple’s logo?
  8. Ten classic optical illu­sions to trick your mind
  9. What do you see?
  10. Fun Mental Rotation challenge
  • Check our Top 25 Brain Teasers, Games and Illusions

Join 35,343 readers exploring, at no cost, the latest in neuroplasticity and brain health.

By subscribing you agree to receive our free, monthly eNewsletter. We don't rent or sell emails collected, and you may unsubscribe at any time.

IMPORTANT: Please check your inbox or spam folder in a couple minutes and confirm your subscription.

Get In Touch!

Contact Us

660 4th Street, Suite 205,
San Francisco, CA 94107 USA

About Us

SharpBrains is an independent market research firm tracking health and performance applications of brain science. We prepare general and tailored market reports, publish consumer guides, produce an annual global and virtual conference, and provide strategic advisory services.

© 2022 SharpBrains. All Rights Reserved - Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.